Turn ETF ideas into real portfolios. Try the builder now →
Cannabis & Psychedelics ETFs
Aggregate data of 7 funds
Performance
Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +21.19% | -1.43% | -5.05% | +88.07% | -10.96% | |
| Flows | +$2M | +$9M | +$14M | +$318M | +$893M | - |
Just published in Cannabis & Psychedelics
A Historic Executive Order: What Federal Action on Psychedelics Means for the Mental Health Landscape
Federal policy has officially caught up with the science and the implications for the psychedelic healthcare sector are significant.
Movers in Cannabis & Psychedelics
Data period: April 15 - 22, 2026
Performance lists exclude leveraged and inverse ETFs
Recently launched ETFs
| Inception | ||
|---|---|---|
Screener search:
Cannabis & Psychedelics ETFsLatest news about Thematic Investing: Cannabis & Psychedelics
A Historic Executive Order: What Federal Action on Psychedelics Means for the Mental Health Landscape
Federal policy has officially caught up with the science and the implications for the psychedelic healthcare sector are significant.
Is U.S. Cannabis Finally Becoming Investable?
Rescheduling alters operating economics in a historically constrained sector.
How Could the Federal Limitations on Intoxicating Hemp Reshape Cannabis Investments?
New federal hemp restrictions and rising rescheduling momentum are reshaping the outlook for cannabis ETFs and U.S. operators.
Is Cannabis Policy Shifting From Politics to Profits?
Federal cannabis rescheduling could reshape U.S. markets. Here’s what it means for businesses, policy, and cannabis ETFs eyeing new growth opportunities.
Can Psychedelics Heal Minds and Grow Portfolios?
Psychedelics offer hope for mental health treatment and attract investors despite biotech-like volatility and market shifts.
Why 2025 Could Be the Biggest Year Yet for Psychedelics and Investors
2025 sees a surge in psychedelic policy reforms, RFK Jr.’s nomination, and growing investor confidence in mental health treatment breakthroughs.
Why the DEA’s Cannabis Rescheduling Delays Matter—and How Advocates Are Fighting Back
Cannabis rescheduling hearings face delays and controversies, reflecting reform complexities and challenges for U.S. advocates.
The Worst Performing ETFs of 2024
Looking at which ETFs had the poorest returns last year.
From Potential to Policy: Cannabis in a New Political Climate
Shifting political tides and GOP support could drive cannabis growth, offering investment opportunities amid evolving U.S. policies.
November Election in the US: Psychedelics
Could the November election ignite a new wave of psychedelic policy in the U.S.?
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs
Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.
ETF Trends
ETF Industry KPIs April 20, 2026
The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.
Asset TV
The ETF Show - Investors Run to Cash Alternatives as Markets Remain Volatile
Jason England, Portfolio Manager and Fixed Income Strategist from Simplify joined The ETF Show to discuss investor allocations to fixed income as markets continue on their rollercoaster ride.
ETF Trends
ETF Industry KPIs March 30, 2026
The ETF Industry saw 33 New Launches, 1 Ticker Change and 9 closures last week.
Browse all educational columns
Have you tried our ETF Compare tool?
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.